Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15917187 | 1.00 | CASP1 (1.00) | CASP1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL29184357 | 0.83 | CASP1 (0.71) | CASP1MAPTMEN1KMT2AGPR35 | |
| SCHEMBL15918360 | 0.83 | CASP1 (0.71) | CASP1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL4632797 | 0.83 | CASP1 (0.70) | CASP1ALDH1A1MEN1KMT2ARAB9A | |
| SCHEMBL4632799 | 0.83 | CASP1 (0.70) | CASP1ALDH1A1MEN1KMT2ARAB9A | |
| SCHEMBL15916867 | 0.82 | CASP1 (0.70) | CASP1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL15917866 | 0.82 | CASP1 (0.70) | CASP1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL15916408 | 0.81 | CASP1 (0.67) | CASP1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL15918201 | 0.80 | CASP1 (0.67) | CASP1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL27167055 | 0.79 | CASP1 (0.66) | CASP1ALDH1A1ADRB2ADRB1AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4398930-A1 | IMMUNOMODULATORY COMBINATIONS OF ANTIGEN AND DRUG-LIPID CONJUGATE | Integrated Nanotherapeutics Inc. (CA) | 2024-07-17 | — | — | EP | claimed |
| WO-2023035068-A1 | IMMUNOMODULATORY COMBINATIONS OF ANTIGEN AND DRUG-LIPID CONJUGATE | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2023-03-16 | — | — | WO | claimed |
| EP-4746880-A2 | METHODS OF TREATING DILATED CARDIOMYOPATHY | Regencor, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2025024320-A2 | METHODS OF TREATING DILATED CARDIOMYOPATHY | REGENCOR, INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| EP-4398930-A1 | IMMUNOMODULATORY COMBINATIONS OF ANTIGEN AND DRUG-LIPID CONJUGATE | Integrated Nanotherapeutics Inc. (CA) | 2024-07-17 | — | — | EP | disclosed |
| WO-2023211929-A1 | PROBES AND METHODS FOR TARGETED VISUALIZATION OF NLRP3 INFLAMMASOMES | VANDERBILT UNIVERSITY (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023035068-A1 | IMMUNOMODULATORY COMBINATIONS OF ANTIGEN AND DRUG-LIPID CONJUGATE | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2023-03-16 | — | — | WO | disclosed |